457146538	457146538	CD	B-NP	O
|	|	NN	I-NP	O
PSH	PSH	NN	I-NP	O
|	|	NN	I-NP	O
80586723	80586723	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0096567	0096567	CD	B-NP	O
|	|	CC	I-NP	O
2/23/2003	2/23/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
COPD	COPD	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
|	|	NNP	B-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/12/2003	2/12/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/15/2003	5/15/2003	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
SAPPENFIELD	SAPPENFIELD	NNP	B-NP	O
,	,	,	O	O
MARCUS	MARCUS	NNP	B-NP	O
659-00-10-3	659-00-10-3	CD	I-NP	O
Ster	Ster	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
9/4/03	9/4/03	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BRIDENSTINE	BRIDENSTINE	NN	B-NP	O
,	,	,	O	O
RAYMOND	RAYMOND	NNP	B-NP	O
Q.	Q.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
650	650	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q4H	Q4H	NN	I-NP	I-protein
PRN	PRN	NN	I-NP	I-protein
headache	headache	NN	I-NP	I-protein
COLACE	COLACE	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
LASIX	LASIX	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
8/3	8/3	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
REG	REG	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
REGULAR	REGULAR	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
SC	SC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
-RRB-	-RRB-	NNP	B-NP	O
QAC	QAC	NNP	I-NP	O
&	&	CC	I-NP	O
HS	HS	NNP	I-NP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
200	200	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	B-protein
OPTICAL	OPTICAL	NNP	I-NP	I-protein
LUBRICANT	LUBRICANT	NNP	I-NP	I-protein
OINTMENT	OINTMENT	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
LACRI-LUBE	LACRI-LUBE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
TOPICAL	TOPICAL	NNP	I-NP	I-protein
OU	OU	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
PREDNISONE	PREDNISONE	NNP	I-NP	I-protein
Taper	Taper	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Give	Give	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
am	am	NN	I-NP	I-protein
X	X	SYM	B-NP	I-protein
2	2	CD	I-NP	I-protein
day	day	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
s	s	VBZ	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
3/1/03	3/1/03	CD	B-NP	O
-04	-04	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
--	--	:	O	O
done	do	VBN	B-VP	O
Give	Give	IN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
am	am	NN	I-NP	O
X	X	SYM	B-NP	O
2	2	CD	I-NP	O
day	day	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	VBZ	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
6/26/03	6/26/03	CD	B-NP	O
-04	-04	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
am	am	NN	I-NP	O
X	X	SYM	B-NP	O
2	2	CD	I-NP	O
day	day	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	VBZ	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
5/25/03	5/25/03	CD	B-NP	O
-04	-04	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	O	O
Give	Give	VB	B-VP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
am	am	NN	I-NP	O
X	X	SYM	B-NP	O
2	2	CD	I-NP	O
day	day	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	VBZ	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
4/18/03	4/18/03	CD	B-NP	O
-04	-04	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	O	O
DARVOCET	DARVOCET	NNP	B-NP	O
N	N	NNP	I-NP	O
100	100	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
PROPOXYPHENE	PROPOXYPHENE	NN	I-NP	B-protein
NAP	NAP	NN	I-NP	I-protein
.	.	.	O	O

/	/	SYM	O	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
2	2	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
QPM	QPM	NN	I-NP	O
OCEAN	OCEAN	NN	I-NP	O
SPRAY	SPRAY	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SODIUM	SODIUM	NN	I-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
0.65	0.65	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
2	2	CD	I-NP	O
SPRAY	SPRAY	NN	I-NP	O
NA	NA	NN	I-NP	O
QID	QID	NN	I-NP	O
PRN	PRN	NN	I-NP	O
dry	dry	JJ	I-NP	O
nose	nose	NN	I-NP	O
PAXIL	PAXIL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
PAROXETINE	PAROXETINE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
4/29/03	4/29/03	CD	B-NP	O
by	by	IN	B-PP	O
AUGER	AUGER	NN	B-NP	B-protein
,	,	,	O	O
SCOTTY	SCOTTY	NNP	B-NP	O
RUDOLF	RUDOLF	NNP	I-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
,	,	,	O	O
MPH	MPH	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
250	250	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
23852764	23852764	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PAROXETINE	PAROXETINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/24/03	6/24/03	CD	B-NP	O
by	by	IN	B-PP	O
TRIMMER	TRIMMER	NN	B-NP	B-protein
,	,	,	O	O
MICHAEL	MICHAEL	NNP	B-NP	O
BILLY	BILLY	NNP	I-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
,	,	,	O	O
MPH	MPH	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	B-NP	B-protein
IV	IV	CD	I-NP	I-protein
250	250	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
Q24H	Q24H	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
29446566	29446566	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PAROXETINE	PAROXETINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/22/03	9/22/03	CD	B-NP	O
by	by	IN	B-PP	O
BERRELL	BERRELL	NNP	B-NP	O
,	,	,	O	O
WARNER	WARNER	NNP	B-NP	O
WILLARD	WILLARD	NNP	I-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
,	,	,	O	O
MPH	MPH	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	B-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
82384862	82384862	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PAROXETINE	PAROXETINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
NORVASC	NORVASC	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

FLOVENT	FLOVENT	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
44	44	CD	B-NP	O
MCG	MCG	NNP	I-NP	O
INH	INH	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LIVOSTIN	LIVOSTIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LEVOCARBASTINE	LEVOCARBASTINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
0.05	0.05	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
2	2	CD	I-NP	O
DROP	DROP	NNP	I-NP	O
OU	OU	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
XALATAN	XALATAN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LATANOPROST	LATANOPROST	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
2	2	CD	I-NP	O
DROP	DROP	NNP	I-NP	O
OU	OU	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
ALPHAGAN	ALPHAGAN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
BRIMONIDINE	BRIMONIDINE	NN	I-NP	O
TARTRATE	TARTRATE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
2	2	CD	I-NP	O
DROP	DROP	NNP	I-NP	O
OS	OS	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
to	to	TO	B-PP	O
R	R	NN	B-NP	O
eye	eye	NN	I-NP	O
only	only	RB	B-ADVP	O
Number	Number	NNP	B-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
250	250	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
X	X	SYM	O	O
14	14	CD	B-NP	O
Days	Day	NNPS	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
6/9	6/9	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/29/03	4/29/03	CD	B-NP	O
by	by	IN	B-PP	O
HADEN	HADEN	NNP	B-NP	O
,	,	,	O	O
KRISTOFER	KRISTOFER	NNP	B-NP	O
JAMIE	JAMIE	NNP	I-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
,	,	,	O	O
MPH	MPH	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
THEOPHYLLINE	THEOPHYLLINE	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PAROXETINE	PAROXETINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
reason	reason	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/24/03	6/24/03	CD	B-NP	O
by	by	IN	B-PP	O
SENGUPTA	SENGUPTA	NNP	B-NP	O
,	,	,	O	O
BLAKE	BLAKE	NNP	B-NP	O
JONAS	JONAS	NNP	I-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
,	,	,	O	O
MPH	MPH	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
THEOPHYLLINE	THEOPHYLLINE	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PAROXETINE	PAROXETINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/22/03	9/22/03	CD	B-NP	O
by	by	IN	B-PP	O
COLBY	COLBY	NNP	B-NP	O
,	,	,	O	O
ANDREAS	ANDREAS	NNP	B-NP	O
LANDON	LANDON	NNP	I-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
,	,	,	O	O
MPH	MPH	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
THEOPHYLLINE	THEOPHYLLINE	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PAROXETINE	PAROXETINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
SINGULAIR	SINGULAIR	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
MONTELUKAST	MONTELUKAST	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QPM	QPM	NNP	I-NP	I-protein
NEXIUM	NEXIUM	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
LANTUS	LANTUS	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
fsbg	fsbg	NN	B-NP	O
is	be	VBZ	B-VP	O
<	<	JJR	B-NP	O
90	90	CD	I-NP	O
CLARINEX	CLARINEX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
DESLORATADINE	DESLORATADINE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
ALBUTEROL	ALBUTEROL	NN	I-NP	O
INHALER	INHALER	NN	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NN	I-NP	O
PRN	PRN	NN	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
ATROVENT	ATROVENT	NN	I-NP	O
INHALER	INHALER	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
IPRATROPIUM	IPRATROPIUM	NN	I-NP	O
INHALER	INHALER	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NN	I-NP	O
CAPTOPRIL	CAPTOPRIL	NN	I-NP	O
37.5	37.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/4/03	9/4/03	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
CAPTOPRIL	CAPTOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
CAPTOPRIL	CAPTOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
ATENOLOL	ATENOLOL	NNP	B-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
8/3	8/3	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr	Dr	NNP	B-NP	O
Hoyt	Hoyt	NNP	I-NP	O
Gieseman	Gieseman	NNP	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
Cephalosporins	Cephalosporin	NNS	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
sob	sob	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
COPD	COPD	NNP	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
OTHER	OTHER	NNP	B-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
asthma	asthma	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
asthma	asthma	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hep	hep	NN	I-NP	O
c	c	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hepatitis	hepatitis	NN	I-NP	O
C	C	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
hep	hep	NN	I-NP	B-protein
b	b	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hepatitis	hepatitis	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
htn	htn	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hypertension	hypertension	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
dm	dm	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
diabetes	diabetes	NN	I-NP	I-protein
mellitus	mellitus	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
depression	depression	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
depression	depression	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
osa	osa	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
sleep	sleep	NN	I-NP	I-protein
apnea	apnea	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
pulmonary	pulmonary	JJ	I-NP	I-protein
htn	htn	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
chf	chf	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
glaucoma	glaucoma	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
glaucoma	glaucoma	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
59yo	59yo	CD	B-NP	O
F	F	NN	I-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
asthma	asthma	NN	I-NP	O
,	,	,	O	O
recent	recent	JJ	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
and	and	CC	O	O
elevated	elevated	JJ	B-NP	O
PA	PA	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
-LRB-	-LRB-	SYM	O	O
50s	50s	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
now	now	RB	B-ADVP	O
presents	present	VBZ	B-VP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
IUOMC	IUOMC	NN	I-NP	O
admission	admission	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
10/13/12	10/13/12	CD	I-NP	O
-RRB-	-RRB-	HYPH	O	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
aggressively	aggressively	RB	B-ADVP	O
-LRB-	-LRB-	IN	B-PP	O
20	20	CD	B-NP	O
pounds	pound	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
diagnosed	diagnose	VBN	B-VP	O
with	with	IN	B-PP	O
OSA	OSA	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
given	give	VBN	I-NP	I-protein
CPAP	CPAP	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
and	and	CC	O	O
received	receive	VBD	B-VP	O
3days	3day	NNS	B-NP	O
of	of	IN	B-PP	O
levo	levo	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
UTI	UTI	NN	I-NP	B-DNA
.	.	.	O	O

She	She	PRP	B-NP	O
now	now	RB	B-ADVP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
SOB	SOB	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
climb	climb	VB	I-VP	O
1	1	CD	B-NP	O
flight	flight	NN	I-NP	O
of	of	IN	B-PP	O
stairs	stair	NNS	B-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
now	now	RB	B-ADVP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
talk	talk	VB	I-VP	O
in	in	IN	B-PP	O
full	full	JJ	B-NP	O
sentences	sentence	NNS	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
PFTs	PFT	NNS	B-NP	O
in	in	IN	B-PP	O
3/16	3/16	CD	B-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
little	little	JJ	B-NP	O
reversibility	reversibility	NN	I-NP	O
.	.	.	O	O

ECHO	ECHO	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
5/13	5/13	CD	I-NP	O
-RRB-	-RRB-	HYPH	B-ADJP	O
:	:	:	O	O
EF59	EF59	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
WMA	WMA	NNP	I-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
,	,	,	O	O
LAE	LAE	NN	B-NP	B-protein
,	,	,	O	O
RV	RV	NN	B-NP	O
pressure	pressure	NN	I-NP	O
is	be	VBZ	B-VP	O
50	50	CD	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
3/18	3/18	CD	I-NP	O
-RRB-	-RRB-	HYPH	B-ADJP	O
:	:	:	O	O
ST	ST	NN	B-NP	B-protein
at	at	IN	B-PP	I-protein
114	114	CD	B-NP	I-protein
.	.	.	O	O

Nl	Nl	NN	B-NP	B-protein
axis	axis	NN	I-NP	O
,	,	,	O	O
poor	poor	JJ	B-NP	O
R	R	NN	I-NP	O
wave	wave	NN	I-NP	O
progre	progre	NN	I-NP	O
ssion	ssion	NN	I-NP	O
,	,	,	O	O
LAE	LAE	NN	B-NP	O
.	.	.	O	O

TwF	TwF	NN	B-NP	O
in	in	IN	B-PP	O
Avl	Avl	NNP	B-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
No	No	DT	B-NP	O
obvious	obvious	JJ	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
,	,	,	O	O
mildly	mildly	RB	B-VP	O
plump	plump	VB	I-VP	O
vessels	vessel	NNS	B-NP	O
,	,	,	O	O
cardiomegaly	cardiomegaly	RB	B-ADVP	O
.	.	.	O	O

Allergies	Allergy	NNS	B-NP	O
:	:	:	O	O
Cefs	Cef	NNS	B-NP	B-protein
-	-	HYPH	O	O
SOB	SOB	NN	B-NP	B-protein
and	and	CC	O	O
hives	hive	VBZ	B-VP	O
Labs	Lab	NNPS	B-NP	B-protein
:	:	:	O	O
WBC	WBC	NNP	B-NP	O
25	25	CD	I-NP	O
.	.	.	O	O

Bands	Band	NNS	B-NP	O
of	of	IN	B-PP	O
23	23	CD	B-NP	O
.	.	.	O	O

BNP	BNP	NN	B-NP	B-protein
862	862	CD	I-NP	I-protein
.	.	.	O	O

PE	PE	NN	B-NP	O
on	on	IN	B-PP	O
admit	admit	NN	B-NP	O
:	:	:	O	O
100.5	100.5	CD	B-NP	O
,	,	,	O	O
p111	p111	NN	B-NP	B-protein
.	.	.	O	O

BP	BP	NN	B-NP	O
137/91	137/91	CD	I-NP	O
.	.	.	O	O

89	89	CD	B-NP	O
%	%	NN	I-NP	O
5L	5L	NN	I-NP	O
.	.	.	O	O

Could	Could	MD	B-VP	O
not	not	RB	I-VP	O
speak	speak	VB	I-VP	O
in	in	IN	B-PP	O
full	full	JJ	B-NP	O
sentences	sentence	NNS	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
resp	resp	VB	I-VP	O
distress	distress	NN	B-NP	O
.	.	.	O	O

Buffalo	Buffalo	NNP	B-NP	O
hump	hump	JJ	I-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
face	face	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
LAD	LAD	NN	I-NP	B-protein
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
at	at	IN	B-PP	O
angle	angle	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
jaw	jaw	NN	I-NP	O
.	.	.	O	O

Tachy	Tachy	NNP	B-NP	O
.	.	.	O	O

Decreased	Decrease	VBN	B-VP	O
BS	BS	NNP	B-NP	O
at	at	IN	B-PP	O
bases	base	NNS	B-NP	O
R	R	NN	I-NP	O
>	>	SYM	B-NP	O
L.	L.	NNP	I-NP	O
mild	mild	JJ	I-NP	O
expiratory	expiratory	JJ	I-NP	O
wheezes	wheeze	NNS	I-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
air	air	NN	I-NP	O
movement.Tachy	movement.Tachy	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
m/r/g	m/r/g	NN	I-NP	O
.	.	.	O	O

Ext	Ext	NN	B-NP	O
warm	warm	JJ	B-ADJP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
to	to	TO	B-PP	O
knees	knee	NNS	B-NP	O
and	and	CC	O	O
trace	trace	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
sacrum	sacrum	NN	I-NP	O
B.	B.	NNP	I-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEM	SYSTEM	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
.	.	.	O	O

Elevated	Elevated	NNP	B-NP	O
WBC	WBC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
25	25	CD	I-NP	O
-RRB-	-RRB-	HYPH	B-ADJP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
shift	shift	NN	I-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
,	,	,	O	O
productive	productive	JJ	B-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
infiltrate	infiltrate	NN	I-NP	O
on	on	IN	B-PP	O
CXR	CXR	NN	B-NP	B-protein
.	.	.	O	O

CT	CT	NN	B-NP	O
scan	scan	NN	I-NP	O
shows	show	VBZ	B-VP	O
Bilateral	Bilateral	NNP	B-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
Levo	Levo	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ceph	ceph	NN	I-NP	O
allergic	allergic	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
culture	culture	NN	I-NP	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
cx	cx	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

By	By	IN	B-PP	O
4/30	4/30	CD	B-NP	O
much	much	JJ	I-NP	O
improved	improve	VBN	I-NP	O
WBC	WBC	NN	I-NP	O
and	and	CC	I-NP	O
breathing	breathing	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pulm	Pulm	NN	B-NP	O
:	:	:	O	O
Likely	Likely	RB	B-ADVP	O
not	not	RB	O	O
an	an	DT	B-NP	O
astham	astham	NN	I-NP	O
flare	flare	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
also	also	RB	B-ADVP	O
likely	likely	RB	B-ADJP	O
with	with	IN	B-PP	O
COPD	COPD	NN	B-NP	O
.	.	.	O	O

Cont	Cont	JJ	B-NP	O
nebulizers	nebulizer	NNS	I-NP	O
,	,	,	O	O
home	home	NN	B-NP	O
meds	med	NNS	I-NP	O
,	,	,	O	O
Prednisone	Prednisone	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
on	on	IN	B-PP	O
taper	taper	NN	B-NP	B-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Initiated	Initiated	NNP	I-NP	O
Flovent	Flovent	NNP	I-NP	O
on	on	IN	B-PP	O
10/8	10/8	CD	B-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Endo	Endo	NNP	B-NP	O
:	:	:	O	O
DM	DM	NN	B-NP	O
on	on	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
24	24	CD	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

With	With	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
elevated	elevate	VBN	B-VP	O
BS	BS	NNP	B-NP	O
.	.	.	O	O

Started	Started	NNP	B-NP	O
Lantus	Lantus	NNP	I-NP	O
for	for	IN	B-PP	O
more	more	RBR	B-NP	O
consistent	consistent	JJ	I-NP	O
coverage	coverage	NN	I-NP	O
.	.	.	O	O

Increase	Increase	NN	B-NP	O
if	if	IN	B-SBAR	O
still	still	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
on	on	IN	B-PP	O
4/10	4/10	CD	B-NP	O
RISS	RISS	NN	I-NP	O
.	.	.	O	O

Hemoglobina	Hemoglobina	NNP	B-NP	O
a1c	a1c	NN	I-NP	O
6.7	6.7	CD	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
.	.	.	O	O

Pump	Pump	NNP	B-NP	O
.	.	.	O	O

Mildly	Mildly	RB	B-NP	O
fluid	fluid	JJ	I-NP	O
overloaded	overloaded	JJ	I-NP	O
goal	goal	NN	I-NP	O
even	even	RB	B-ADVP	O
to	to	TO	B-PP	O
-500	-500	CD	B-NP	O
cc	cc	NN	I-NP	O
.	.	.	O	O

Creat	Creat	NN	B-NP	O
bumped	bump	VBN	B-VP	O
with	with	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
diuresisi	diuresisi	NNS	I-NP	O
.	.	.	O	O

Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
BID	BID	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
.	.	.	O	O

HTN	HTN	NN	B-NP	B-protein
.	.	.	O	O

Cont	Cont	NNP	B-NP	O
Norvasc	Norvasc	NNP	I-NP	O
-	-	HYPH	B-VP	O
now	now	RB	B-ADVP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
,	,	,	O	O
Captopril	Captopril	NNP	B-NP	O
decreased	decrease	VBD	B-VP	O
on	on	IN	B-PP	O
5/15	5/15	CD	B-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-VP	O
creat	creat	VB	I-VP	O
bump	bump	NN	B-NP	O
.	.	.	O	O

Now	Now	RB	B-ADVP	O
added	add	VBN	B-VP	O
Lopressor	Lopressor	NN	B-NP	B-protein
12.5	12.5	CD	I-NP	I-protein
-	-	HYPH	I-NP	O
titrate	titrate	NN	I-NP	O
up	up	RP	B-PRT	O
if	if	IN	B-SBAR	O
called	call	VBN	B-VP	O
for	for	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
BP	BP	NN	I-NP	O
.	.	.	O	O

Watch	Watch	VB	B-VP	O
for	for	IN	B-PP	O
wheezing	wheeze	VBG	B-VP	O
though	though	IN	B-SBAR	O
given	give	VBN	B-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Rheum	Rheum	NN	B-NP	O
:	:	:	O	O
COnt	COnt	NNP	B-NP	O
Darvocet	Darvocet	NNP	I-NP	O
,	,	,	O	O
celebrex	celebrex	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
with	with	IN	B-PP	O
ARI	ARI	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
baseline	baseline	NN	I-NP	O
creat	creat	NN	I-NP	O
1.2	1.2	CD	I-NP	O
at	at	IN	B-PP	O
AWLMH	AWLMH	NN	B-NP	B-protein
5/13	5/13	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Likely	Likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
diuresesis	diuresesis	NN	B-NP	O
,	,	,	O	O
ACE	ACE	NN	B-NP	O
,	,	,	O	O
CT	CT	NN	B-NP	O
dye	dye	NN	I-NP	O
.	.	.	O	O

Now	Now	RB	B-ADVP	O
declining	decline	VBG	B-VP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
LITANO	LITANO	NNP	B-NP	O
,	,	,	O	O
ANGELO	ANGELO	NNP	B-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
******	******	NNP	I-NP	O
END	END	NNP	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NNP	B-NP	O
ORDERS	ORDERS	NNP	I-NP	O
******	******	SYM	B-NP	O

